Influence of Residual Stenosis on Clinical Outcome and Restenosis After Middle Cerebral Artery Stenting
- First Online:
- 155 Downloads
The purpose of this study was to assess whether the residual stenosis has effect on restenosis after stenting for atherosclerotic stenosis in the middle cerebral artery.
Sixty-seven patients underwent 69 single-stent procedures successfully for atherosclerotic stenosis ≥70% in the M1 segment of middle cerebral artery were reviewed retrospectively. All patients were classified into two groups: nonresidual (≤30%) and residual (>30%) stenosis. The influence of residual stenosis immediately after stent placement on clinical outcomes and restenosis at follow-up was analyzed. Restenosis was defined as ≥20% stenosis on angiographic follow-up imaging after excluding postoperative residual stenosis.
Between groups, it was no difference in the conventional risk factors of cerebrovascular diseases, characteristics of targeted vessels, and types of stent. The residual stenosis had no influence on any stroke or death, but the ipsilateral stroke had a trend in the residual stenosis group. The incidence of restenosis was higher in patients with residual stenosis >30% (17% vs. 45.5%, P = 0.04), and the increase of percent stenosis was 7.9 ± 11.7 and 17.1 ± 15.4, respectively (P = 0.03). The correlation coefficient was r = 0.37 (P < 0.01) between the residual stenosis and the increase of percent stenosis. Univariate and multivariate regression analysis showed that residual stenosis >30% was an independent risk factor for restenosis at follow-up (log-rank, Chi-square = 6.09, P = 0.01).
Residual stenosis immediately after stenting for atherosclerotic middle cerebral artery stenosis may be a predictor of clinical outcomes and restenosis at follow-up.
KeywordsMiddle cerebral artery Restenosis Stenosis Stenting Stroke
- 8.Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, Kim WC, Joo JY (2004) Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 75(6):847–851PubMedCrossRefGoogle Scholar
- 15.Yue X, Yin Q, Xi G, Zhu W, Xu G, Zhang R, Zhou Z, Ma M, Jin G, Liu X (2010) Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis. Cardiovasc Intervent Radiol. Epub ahead of printGoogle Scholar
- 18.Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr (2004) Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 109(22):2727–2731PubMedCrossRefGoogle Scholar
- 21.Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN et al (2007) U.S. multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 38(3):881–887PubMedCrossRefGoogle Scholar